Macquarie Group looks set to acquire Britain’s Green Investment Bank (GIB) after a court rejected the claim of a rival bidder on Friday.
The government decided to sell a majority stake in 2015, saying it would give the bank greater freedom to borrow, removing state aid restrictions, and allow it to attract more capital.
In September last year, it selected a Macquarie-led group as the preferred bidder, but competing bidder Sustainable Development Capital (SDCL) went to court, arguing the consortium hadn’t met criteria set out to guide ministers in their decision.
In a statement on Friday, SDCL announced it had lost its judicial review in the High Court.
According to the High Court judgement, the British government viewed the bid by the Macquarie consortium, which also includes Universities Superannuation Scheme, as “financially preferable” over the SDCL-led bid for several reasons.
SDCL’s funding position was “less secure” because it reduced its offer to buy 100 per cent of the bank to 75 per cent, after one of the members of its consortium pulled out in August.
Full Content: The Sidney Morning Herald
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas